DNA Liquid B Cancer Test & Reports

DNA Liquid B marks a significant advancement in the detection, treatment, and monitoring of cancer. As the clinical approach to cancer shifts towards managing it as a chronic condition, consistent and easy assessment of cancer markers becomes imperative. By scrutinizing cancer signals present in the blood, DNA Liquid B empowers healthcare professionals to enhance prevention through early detection, ascertain treatment effectiveness, and monitor for potential disease resurgence or recurrence. 

• Access Early Detection: By scrutinizing cancer signals present in the blood, DNA Liquid B enables early detection, enhancing prevention efforts. 
• Improve Treatment Effectiveness: Leveraging next-generation sequencing technology, DNA Liquid B assesses treatment effectiveness, guiding personalized therapeutic strategies. 
• Comprehensive, Proactive Monitoring: With detailed reports encompassing up to 16 types of cancer, DNA Liquid B provides ongoing monitoring for potential disease resurgence or recurrence, empowering proactive healthcare management.

**Please Note: Due to local laws and regulations, we currently DO NOT offer our Liquid B Test outside the US, and DO NOT service New York, New Jersey and Rhode Island at this time.